Month: March 2025

PRESS RELEASE Arcueil, March 10, 2025 Declaration of transactions on own shares conducted from March 03 to March 07, 2025 Within the framework of the authorizations granted by the General Assembly on February 4, 2025, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from March 03 to March 07, 2025 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2025-03-04 FR0014003U94 5,000. 7.6766 XPARAramis Group 9695002Q984W0T41WB42 2025-03-05 FR0014003U94 81 7.7600 ...

KPN has repurchased 1,809,964 KPN ordinary shares in the period from 3 March to 7 March 2025. The shares were repurchased at an average price of € 3.64 per share for a total consideration of € 6.6m. These repurchases are part of the € 250m share buyback started on 25 February 2025 and reflect KPN’s commitment to structurally return additional capital to its shareholders. The total number of ordinary shares repurchased to date is 3,154,964 for a total consideration of € 11.5m. Transaction details of the share buyback are available on our website. Formal disclosures: Royal KPN N.V. Head of IR: Matthijs van Leijenhorst Inside information: Yes Topic: KPN reports on progress of € 250m share buyback10/03/2025KPN-SBBAttachmentKPN reports on progress of EUR 250m share buyback

Sláturfélag Suðurlands hefur gefið út ársskýrslu ársins 2024. Sjá má skýrsluna í viðhengi. AttachmentÁrsskýrsla 2024

Stock Buyback Program commencing from today, with broker engaged to execute any open market purchases Stock Buyback Program previously announced in April 2024 to be extended for an additional 15 months to June 30, 2026 LONDON, March 10, 2025 (GLOBE NEWSWIRE) — VivoPower International (Nasdaq: VVPR) (“VivoPower” or the “Company”) today announced that its Board of Directors (the “Board”) has authorized the extension of a capital management strategy including a stock buyback program (the “Stock Buyback Program”) pursuant to which the Company is authorized to purchase up to US$5 million of the Company’s outstanding ordinary shares. The Stock Buyback Program now has an updated expiration date of June 30, 2026, and maybe suspended, terminated, amended or modified by the Board at any time...

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants SOUTH JORDAN, Utah, March 10, 2025 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in premature infants (PREEMIE study). PDA is a congenital heart condition that occurs when the ductus arteriosus, a blood vessel connecting the aorta and pulmonary artery, does not close following birth. The condition is common in premature, low-birth-weight infants. A PDA affects the way blood flows through a baby’s lungs. A hemodynamically significant...

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is excited to announce that it has signed a distribution agreement with Duchefa Farma B.V. (“Duchefa”) of Haarlem, Netherlands, to act as exclusive distribution agent for its LaNeo MDMA in the Netherlands market. “Last year, the Dutch State Commission on MDMA made a strong recommendation that the Government of the Netherlands allow for the use of MDMA in the Dutch healthcare system,” said Marten Teves, Owner, Duchefa Farma. “We believe that PharmAla is the most diligent and reputable manufacturer of pharmaceutical MDMA in the world, and are proud to exclusively...

PITTSBURGH, March 10, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in laser technology, announces the release of its AIM FL series of industrial, multi-kilowatt single mode fiber lasers. This innovative product family includes up to 3kW single mode operation with practical industrial fiber delivery (up to 10m) and an impressive water-cooling temperature range of 20°C to 35°C. The AIM FL series has been rigorously designed with the needs of customers in high precision manufacturing applications in mind and offers customers the highest levels of performance and versatility that they have come to expect from Coherent. Precisely aimed at industrial welding applicationsWelding engineers in industries such as automotive, medical device manufacturing, and consumer goods are constantly pushing the envelope, resulting...

NEW CANAAN, Conn., March 10, 2025 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that Anthony Coniglio, President and CEO, will present at the Sidoti Virtual Investor Conference to be held March 19-20, 2025. Sidoti Small Cap Conference Presentation Details:Date: Thursday, March 20, 2025Time: 10:00-10:30 A.M. ET in Track 5Webcast: https://sidoti.zoom.us/webinar/register/WN_xUxDYWQvTSOgiYu0W2WHsA To schedule a one-on-one meeting with NewLake’s management team, please email KCSA Strategic Communications at NewLake@KCSA.com. About NewLake Capital Partners, Inc.NewLake Capital Partners, Inc. is an internally-managed real estate investment trust (“REIT”) that provides real estate capital to state-licensed...